Maison De Sante Protestante Bagatelle

At Maison De Sante Protestante Bagatelle, clinical trials in digestive system diseases focus mainly on colon cancer, colon carcinoma, and colon cancer with liver metastasis. These studies are designed to improve treatment choices, refine follow-up after surgery, and strengthen long-term outcomes for people with colorectal malignancies.

• Testing how circulating tumor DNA can guide treatment decisions after surgery
• Evaluating chemotherapy approaches for high-risk and stage III colorectal cancer
• Comparing strategies aimed at improving disease-free survival and relapse-free survival

The research also includes work on treatment effectiveness in older adults and on options for metastatic disease, reflecting a strong focus on personalized care in oncology.

The site is active in neoplasm research centered on advanced colorectal cancer, including cases where the disease has spread to the liver. These trials examine different ways to deliver treatment and assess whether new care strategies can better control disease progression.

• Studying treatment approaches for metastatic colorectal cancer restricted to the liver
• Comparing intra-arterial and intravenous chemotherapy delivery
• Measuring progression-free survival and clinical response

This area of research aims to improve how advanced cancer is managed, with attention to both effectiveness and the practical delivery of therapy.

In the urology department, clinical research also addresses primary premature ejaculation, a condition that can affect sexual health and quality of life. The trial activity here is focused on evaluating whether a new therapy can improve symptoms more effectively than placebo.

• Assessing symptom improvement in primary premature ejaculation
• Exploring better treatment options for adult patients
• Supporting research into reproductive and urinary health

This work broadens the site’s clinical portfolio beyond cancer, showing interest in conditions that directly affect daily well-being and patient confidence.

The research program includes studies in moderate to severe Crohn’s disease with at least one active perianal fistula. These trials aim to improve control of inflammatory bowel disease and evaluate therapies that may help reduce fistula-related symptoms and complications.

• Investigating treatment options for fistulising Crohn’s disease
• Aiming to improve symptom control and disease management
• Focusing on digestive system inflammation and patient quality of life

This area highlights the site’s involvement in complex gastrointestinal research, with attention to both disease activity and the burden of chronic intestinal inflammation.